Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$66,741
-$705,207 QoQ
Shares Held
36,874
-67.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LMR Partners LLP holds $133,764,593 across 60 Biotechnology names. OCGN ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
74,661 | $24,703,084 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
324,939 | $18,355,804 | |
| 3 | ARGX |
Argenx SE
|
23,488 | $17,152,112 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
130,000 | $12,642,500 | |
| 5 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
116,444 | $9,771,980 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,853 | $8,865,158 | |
| 7 | ABVX |
Abivax S.A.
|
76,552 | $8,524,065 | |
| 8 | NKTR |
Nektar Therapeutics
|
48,294 | $3,474,753 |
All Filings in OCGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66,741 | 36,874 | Shares | Other | 2026-05-15 | |
| 2021-03-31 | $771,948 | 113,689 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $25,797 | 14,097 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||